"Until I looked at the financials, the recent changes to the balance sheet - and especially the elimination of the toxic debt, I would not have considered buying and holding a pink stock. I don't usually even trade in anything under a quarter.
Here, I am convinced that the valuation is well over a buck without factoring FDA approval. And yes, I realize that they let this go to the pinks while trying to pay for FDA trials. Crazy!
As a general rule, pinks are for quick in and out plays. This one IMO is the Hope diamond in the rough."
Market Data 
Markets 
AI
